You can buy or sell Catalent and other stocks, options, ETFs, and crypto commission-free!
CATALENT, INC., also called Catalent, is a holding company, which engages in the provision of delivery technologies and development solutions for drugs, biologics, and consumer and animal health products. It operates through the following segments: Softgel Technologies, Biologics and Specialty Drug Delivery, Oral Drug Delivery, and Clinical Supply Services. Read More The Softgel Technologies segment focuses on the formulation, development, and manufacture of prescription and consumer health soft capsules, softgels, vegicaps and optishell capsules. The Biologics and Specialty Drug Delivery segment researches and develop biologic drug products in prefilled syringes, vials, cartridges, blow-fill-seal unit doses, and injectable formats. The Oral Drug Delivery segment offers formulates oral dosage forms. The Clinical Supply Services segment includes the packaging, labeling, storage, distribution, and inventory management of patient kits for clinical trials of drugs. It also provides clinical e-solutions and informatics, and global comparator sourcing services. The company was founded in April 2007 and is headquartered in Somerset, NJ.
Somerset, New Jersey
52 Week High
52 Week Low
Yahoo FinanceMay 13
Edited Transcript of CTLT earnings conference call or presentation 7-May-19 12:15pm GMT
Q3 2019 Catalent Inc Earnings Call Somerset May 13, 2019 (Thomson StreetEvents) -- Edited Transcript of Catalent Inc earnings conference call or presentation Tuesday, May 7, 2019 at 12:15:00pm GMT TEXT version of Transcript Scroll to continue with content Ad ================================================================================ Corporate Participants ================================================================================ * John R. Chiminski Catalent, Inc. - Chairman & CEO * Thoma...
Catalent (CTLT) Surpasses Q3 Earnings Estimates
Catalent (CTLT) came out with quarterly earnings of $0.49 per share, beating the Zacks Consensus Estimate of $0.45 per share. This compares to earnings of $0.41 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 8.89%. A quarter ago, it was expected that this maker of drug delivery technologies would pos t earnings of $0.37 per share when it actually produced earnings of $0.45, delivering a surprise of 21.62%. Over the last fo...
Yahoo FinanceMay 7
Catalent: Fiscal 3Q Earnings Snapshot
SOMERSET, N.J. (AP) _ Catalent Inc. (CTLT) on Tuesday reported fiscal third-quarter profit of $31.7 million. The Somerset, New Jersey-based company said it had net income of 22 cents per share. Earnings, adjusted for one-time gains and costs, were 49 cents per share. The results topped Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for earnings of 45 cents per share. The maker of drug delivery technologies posted revenue of $617.5 million in the ...
$0.46 per share
$0.49 per share